Ramin Faghih

Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 261 citations

Medicine, Neuroscience, Pharmacology +13

4-(2-[2-(2(<i>R</i>)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and Related 2-Aminoethylbenzofuran H₃ Receptor Antagonists Potently Enhance Cognition and Attention

Marlon Cowart, Ramin Faghih, Michael P. Curtis et al. · Journal of Medicinal Chemistry · 2004 · 122 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup

Gerard B. Fox, Jia Bao Pan, Timothy A. Esbenshade et al. · Behavioural Brain Research · 2002 · 114 citations

Medicine, Neuroscience, Pharmacology +13

Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects

Timothy A. Esbenshade, Kathleen M. Krueger, Thomas R. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 102 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Two Novel and Selective Nonimidazole H3 Receptor Antagonists A-304121 and A-317920: II. In Vivo Behavioral and Neurophysiological Characterization

Gerard B. Fox, Jia Bao Pan, Richard J. Radek et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 101 citations

Medicine, Neuroscience, Pharmacology +9